CII
NVCR icon

Capital International Inc’s NovoCure NVCR Stock Holding History

Capital International Inc’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,205
Closed -$1.02M – 316
2024
Q4 		$1.02M Hold
34,205
– – 0.01% 287
2024
Q3 		$535K Hold
34,205
– – 0.01% 293
2024
Q2 		$586K Hold
34,205
– – 0.01% 298
2024
Q1 		$535K Hold
34,205
– – 0.01% 302
2023
Q4 		$511K Buy
34,205
+13,798
+68% +$185K 0.01% 308
2023
Q3 		$330K Sell
20,407
-57,947
-74% -$1.67M 0.01% 318
2023
Q2 		$3.25M Sell
78,354
-8,711
-10% -$541K 0.06% 212
2023
Q1 		$5.24M Buy
87,065
+5,055
+6% +$404K 0.11% 165
2022
Q4 		$6.02M Sell
82,010
-2,334
-3% -$176K 0.13% 160
2022
Q3 		$6.41M Sell
84,344
-35,676
-30% -$2.78M 0.14% 152
2022
Q2 		$8.34M Sell
120,020
-396
-0.3% -$29.8K 0.12% 153
2022
Q1 		$9.98M Sell
120,416
-32,941
-21% -$2.43M 0.11% 152
2021
Q4 		$11.5M Buy
153,357
+8,947
+6% +$898K 0.11% 160
2021
Q3 		$16.8M Sell
144,410
-4,388
-3% -$663K 0.16% 136
2021
Q2 		$33M Buy
148,798
+29,527
+25% +$5.74M 0.29% 112
2021
Q1 		$15.8M Sell
119,271
-4,391
-4% -$695K 0.15% 139
2020
Q4 		$21.4M Buy
123,662
+4,818
+4% +$659K 0.2% 122
2020
Q3 		$13.2M Buy
118,844
+50,296
+73% +$4.02M 0.15% 134
2020
Q2 		$4.07M Buy
68,548
+14,663
+27% +$964K 0.05% 174
2020
Q1 		$3.63M Buy
+53,885
New +$4.26M 0.06% 150

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Capital International Inc's NVCR Position: Q1 2025 in Review

Capital International Inc sold out of NovoCure (NVCR) in Q1 2025, closing a stake of 34,205 shares — an estimated $1.02M sold.

Capital International Inc first reported a position in NVCR in Q1 2020 and held it in 20 quarters. The position peaked at $33M in Q2 2021. 227 funds tracked by Wall St. Rank hold NVCR as of Q1 2025.

  • Capital International Inc reported no remaining NovoCure position as of Q1 2025 after selling out during the quarter.
  • Capital International Inc sold 34,205 NovoCure shares in Q1 2025, an estimated $1.02M.
  • Capital International Inc first reported a position in NovoCure in Q1 2020 and held it in 20 quarters.
  • Capital International Inc's NovoCure position peaked at $33M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held NovoCure as of Q1 2025.

Based on Capital International Inc's 13F filing for Q1 2025, filed 12 May 2025.